Clinical trials: Heroin Use Disorder

Opioid Use Disorder

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

• Completed
• Age: 18 to 60 years
• Phase 3
• Results posted

This study will evaluate the safety, effectiveness and tolerance of low doses of oral naltrexone along with buprenorphine to treat opioid use disorder prior to the first injection of VIVITROL.

Trial name

NCT02537574

Testing

NTX/BUP, NTX/PBO-B, PBO-N/PBO-B

Where

20 sites in United States

Volunteers

380 people

Sponsor

Alkermes, Inc.